GB2122198B - Antiviral guanine derivatives - Google Patents
Antiviral guanine derivativesInfo
- Publication number
- GB2122198B GB2122198B GB08316743A GB8316743A GB2122198B GB 2122198 B GB2122198 B GB 2122198B GB 08316743 A GB08316743 A GB 08316743A GB 8316743 A GB8316743 A GB 8316743A GB 2122198 B GB2122198 B GB 2122198B
- Authority
- GB
- United Kingdom
- Prior art keywords
- methoxy
- fluoro
- hydrogen
- methylthio
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/04—Saturated ethers
- C07C43/13—Saturated ethers containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/16—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8203855A SE8203855D0 (sv) | 1982-06-21 | 1982-06-21 | Novel derivatives of guanine i |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8316743D0 GB8316743D0 (en) | 1983-07-20 |
| GB2122198A GB2122198A (en) | 1984-01-11 |
| GB2122198B true GB2122198B (en) | 1985-11-06 |
Family
ID=20347137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB08316743A Expired GB2122198B (en) | 1982-06-21 | 1983-06-20 | Antiviral guanine derivatives |
Country Status (17)
| Country | Link |
|---|---|
| EP (2) | EP0112353A1 (enExample) |
| JP (1) | JPS59501112A (enExample) |
| KR (1) | KR840005141A (enExample) |
| AT (1) | ATE18225T1 (enExample) |
| AU (1) | AU1706083A (enExample) |
| DD (1) | DD210274A5 (enExample) |
| DE (1) | DE3362283D1 (enExample) |
| ES (1) | ES523425A0 (enExample) |
| GB (1) | GB2122198B (enExample) |
| GR (1) | GR78621B (enExample) |
| IS (1) | IS2822A7 (enExample) |
| NZ (1) | NZ204640A (enExample) |
| PH (1) | PH19399A (enExample) |
| PT (1) | PT76902B (enExample) |
| SE (1) | SE8203855D0 (enExample) |
| WO (1) | WO1984000167A1 (enExample) |
| ZA (1) | ZA834532B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5684153A (en) | 1984-08-16 | 1997-11-04 | Beecham Group Plc | Process for the preparation of purine derivatives |
| IL73682A (en) * | 1983-12-20 | 1991-08-16 | Medivir Ab | Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation |
| DE3571810D1 (en) * | 1984-01-26 | 1989-08-31 | Merck & Co Inc | Substituted butyl guanines and their utilization in antiviral compositions |
| US4617304A (en) * | 1984-04-10 | 1986-10-14 | Merck & Co., Inc. | Purine derivatives |
| ES2001094A6 (es) * | 1985-08-16 | 1988-04-16 | Glaxo Group Ltd | Un procedimiento para la preparacion de un derivado de guanina |
| DE3627024A1 (de) | 1985-09-24 | 1987-04-02 | Hoechst Ag | In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine |
| DE3604899A1 (de) * | 1986-02-17 | 1987-08-20 | Hoechst Ag | Chirale umsetzungsprodukte aus mesogenen molekuelbausteinen und bifunktionell reaktionsfaehigen butantetraolderivaten und ihre verwendung als dotierstoff in fluessigkristall-phasen |
| WO1988003923A1 (fr) * | 1986-11-25 | 1988-06-02 | Institut Organicheskogo Sinteza Akademii Nauk Latv | Guanines substitutees en position 9 |
| US4973318A (en) * | 1988-02-10 | 1990-11-27 | D.C.P. Af 1988 A/S | Disposable syringe |
| US5216141A (en) * | 1988-06-06 | 1993-06-01 | Benner Steven A | Oligonucleotide analogs containing sulfur linkages |
| US4966895A (en) * | 1989-02-02 | 1990-10-30 | Merck & Co. Inc. | Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents |
| CA2347973C (en) | 1999-07-20 | 2010-06-22 | Morphosys Ag | Novel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1523865A (en) * | 1974-09-02 | 1978-09-06 | Wellcome Found | Purine compunds and salts thereof |
| US4230708A (en) * | 1977-10-20 | 1980-10-28 | Stichting Rega V.Z.W. | Therapeutic application of (S) -or (RS)-9-(2, 3-dihydroxypropyl) adenine for use as antiviral agents |
| US4221910A (en) * | 1978-09-15 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | 9-(Hydroxy alkyl)purines |
| IL64501A (en) * | 1980-12-22 | 1985-07-31 | Astra Laekemedel Ab | 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use |
-
1982
- 1982-06-21 SE SE8203855A patent/SE8203855D0/xx unknown
-
1983
- 1983-06-20 EP EP83901965A patent/EP0112353A1/en active Pending
- 1983-06-20 WO PCT/SE1983/000254 patent/WO1984000167A1/en not_active Ceased
- 1983-06-20 GR GR71722A patent/GR78621B/el unknown
- 1983-06-20 ES ES523425A patent/ES523425A0/es active Granted
- 1983-06-20 PH PH29089A patent/PH19399A/en unknown
- 1983-06-20 EP EP83850170A patent/EP0103551B1/en not_active Expired
- 1983-06-20 PT PT76902A patent/PT76902B/pt unknown
- 1983-06-20 AU AU17060/83A patent/AU1706083A/en not_active Abandoned
- 1983-06-20 AT AT83850170T patent/ATE18225T1/de not_active IP Right Cessation
- 1983-06-20 NZ NZ204640A patent/NZ204640A/en unknown
- 1983-06-20 JP JP58502135A patent/JPS59501112A/ja active Pending
- 1983-06-20 DE DE8383850170T patent/DE3362283D1/de not_active Expired
- 1983-06-20 GB GB08316743A patent/GB2122198B/en not_active Expired
- 1983-06-21 ZA ZA834532A patent/ZA834532B/xx unknown
- 1983-06-21 KR KR1019830002777A patent/KR840005141A/ko not_active Withdrawn
- 1983-06-21 IS IS2822A patent/IS2822A7/is unknown
- 1983-06-21 DD DD83252201A patent/DD210274A5/de unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH19399A (en) | 1986-04-10 |
| EP0103551A3 (en) | 1984-06-13 |
| EP0112353A1 (en) | 1984-07-04 |
| NZ204640A (en) | 1986-07-11 |
| SE8203855D0 (sv) | 1982-06-21 |
| EP0103551B1 (en) | 1986-02-26 |
| PT76902A (en) | 1983-07-01 |
| ZA834532B (en) | 1984-03-28 |
| EP0103551A2 (en) | 1984-03-21 |
| ATE18225T1 (de) | 1986-03-15 |
| GB2122198A (en) | 1984-01-11 |
| IS2822A7 (is) | 1986-02-28 |
| ES8500942A1 (es) | 1984-11-01 |
| GB8316743D0 (en) | 1983-07-20 |
| AU1706083A (en) | 1984-01-26 |
| JPS59501112A (ja) | 1984-06-28 |
| GR78621B (enExample) | 1984-09-27 |
| DD210274A5 (de) | 1984-06-06 |
| KR840005141A (ko) | 1984-11-03 |
| PT76902B (en) | 1986-04-09 |
| ES523425A0 (es) | 1984-11-01 |
| DE3362283D1 (en) | 1986-04-03 |
| WO1984000167A1 (en) | 1984-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU529426B2 (en) | 4-amino-2-ureido-pyrimidine-5-carboxylic acid anilides and their use in treating lipometabolism disturbances and adiposity | |
| AU542373B2 (en) | Guanine derivatives | |
| DE3362283D1 (en) | Novel derivatives of guanine | |
| GR890300125T1 (en) | Billiary acid derivatives, processes for the preparation thereof and phamaceutical compositions containing them | |
| IL100805A0 (en) | Benzyloxyphenyl derivatives,their preparation and pharmaceutical compositions containing them | |
| IE830607L (en) | Imidazolylphenylpyridazinones | |
| GB2122197B (en) | Antiviral guanine derivatives | |
| EP0055444A3 (en) | Trisubstituted pyrimido(5,4-d)pyrimidines, their preparation and their use as medicines | |
| NZ217418A (en) | Tricyclic heterocyclic compounds and pharmaceutical compositions | |
| DE3167347D1 (en) | New benzothiazine derivatives, processes for preparation thereof and use thereof | |
| DK228086D0 (da) | Substituerede isoxazol-derivater med antiviral virkning og fremgangsmaade af saadanne derivater | |
| DE3880304D1 (de) | 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung. | |
| IL92402A0 (en) | Pyrimidine nucleoside derivatives,their preparation and pharmaceutical compositions containing them | |
| DK0459176T3 (da) | Oligophosphater med antiviral virkning | |
| DK105183D0 (da) | Fremgangsmade til fremstilling af 1,4-diaminocyclitolderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |